bromodeoxyuridine has been researched along with Pancreatitis, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bethge, S; Bobrowski, A; Mueller-Graf, F; Spitzner, M; Vollmar, B; Zechner, D | 1 |
1 other study(ies) available for bromodeoxyuridine and Pancreatitis, Chronic
| Article | Year |
|---|---|
Risk factors for pancreatic ductal adenocarcinoma specifically stimulate pancreatic duct glands in mice.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Pancreatic Ductal; Ceruletide; Diabetes Mellitus, Type 2; Humans; Male; Metaplasia; Mice; Mice, Obese; Mucins; Neoplasm Proteins; Pancreatic Ducts; Pancreatic Neoplasms; Pancreatitis, Chronic; Risk Factors | 2013 |